Dr. Deborah A. Goss, MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- Creighton University School of Medicine (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 341
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: Creighton University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
NJ license 25MA06851700 -
Critical Care Medicine (Internal Medicine) Physician
NJ license 25MA06851700 -
Specialist
NJ license 25MA06851700
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hackensack University Medical Center Hackensack, NJ
- Englewood Hospital and Medical Center Englewood, NJ
- Holy Name Medical Center Teaneck, NJ
Medical groups
- Hackensack Sleep and Pulmonary Center LLC. (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 341
- Services billed
- 1,732
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 577 | 249 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 295 | 51 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 266 | 41 |
| New patient office or other outpatient visit, 45-59 minutes | 76 | 76 |
| Established patient office or other outpatient visit, 20-29 minutes | 75 | 53 |
| Test to examine how well the lungs exchange gases | 66 | 66 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 65 | 65 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 50 | 29 |
| Test to determine lung volumes using sensors | 35 | 35 |
| Test to determine lung volumes using gas dilution or washout | 30 | 30 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Hackensack, NJ | 279 |
| Dexamethasone Other prescribers in Hackensack, NJ | 227 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Hackensack, NJ | 193 |
| Azithromycin Other prescribers in Hackensack, NJ | 155 |
| Montelukast Sodium Other prescribers in Hackensack, NJ | 152 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Hackensack, NJ | 135 |
| Pantoprazole Sodium Other prescribers in Hackensack, NJ | 112 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Hackensack, NJ | 52 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Hackensack, NJ | 50 |
| Doxycycline Hyclate Other prescribers in Hackensack, NJ | 47 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 81 payments worth $1,660 in total to this clinician.
| Inspire Medical Systems, Inc. | $241 |
|---|---|
| Jazz Pharmaceuticals Inc. | $237 |
| GlaxoSmithKline, LLC. | $221 |
| AstraZeneca Pharmaceuticals LP | $220 |
| Axsome Therapeutics, Inc. | $157 |
| Avadel Cns Pharmaceuticals, LLC | $141 |
| Harmony Biosciences LLC | $133 |
| Baxter Healthcare | $126 |
| Food and Beverage | $1,438 |
|---|---|
| Consulting Fee | $150 |
| Education | $72.37 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. Feb 13, 2025 | Consulting Fee XYWAV; XYREM · NEUROLOGY | $150 |
| Harmony Biosciences LLC Jun 11, 2025 | Education in-kind | $54.99 |
| Insmed, Inc. Aug 14, 2025 | Education in-kind | $17.38 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $200,055 in research payments for these studies, mostly to the institutions running them.
- (OSPREY)Treating Obstructive Sleep APnea using TaRgetEd HYpoglossal Neurostimulation
Livanova USA, Inc. - OSPREY
Livanova USA, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.